UCL Cancer Symposium 2024

Last chance to register for UCL's flagship cross-faculty cancer event.

Extra Tickets Released after Selling Out

The UCL Cancer Symposium, organised by the UCL Cancer Domain, is UCL’s flagship cross-faculty cancer research event, showcasing the incredible range of exciting and impactful research taking place at UCL. The event, featuring keynote speaker Professor Charles Swanton (UCL Cancer Institute and the Francis Crick Institute), connects researchers from a uniquely wide range of disciplines, across all career levels, and showcases UCL’s leading position in this field.

In-person tickets initially sold out for the symposium but a few more have just been made available on the Eventbrite page below.

UCL Cancer Symposium 2024 Speakers

Charles Swanton, Chair in Personalised Medicine, Research Department of Oncology, UCL
Maria Secrier, Associate Professor in Computational Cancer Biology, Department of Genetics, Evolution and Environment, UCL
Kasper Fugger, Group Leader - UCL Cancer Institute and Visiting Scientist, Francis Crick Institute
Marnix Jansen, Clinical Professorial Research Fellow, Research Department of Pathology, UCL Cancer Institute
Brieuc Lehmann, Lecturer (Assistant Professor), Department of Statistical Science, UCL
Tariq Enver, Director, UCL Cancer Institute; Cancer Lead, UCLP AHSC; Lead, CRUK City of London Centre
J.P. Martinez-Barbera, Professor of Developmental Biology and Cancer, Developmental Biology & Cancer Department, UCL GOS Institute of Child Health
Sara Ghorashian, Honorary Associate Professor, Developmental Biology & Cancer Department, UCL GOS Institute of Child Health
Karen Page, Professor of Mathematical Biology, Department of Mathematics
Steve Harris, Principal Clinical Research Fellow, Clinical Epidemiology, UCL
Grant Mills, Professor of Healthcare Infrastructure Delivery, The Bartlett School of Sustainable Construction, UCL
John Kelly, Professor of Uro-Oncology, Division of Surgery & Interventional Science, UCL

The symposium also features three networking sessions, to view posters, meet colleagues and make new connections.

Introducing our Major Sponsor Stratech

We are excited to announce details of the lunchtime workshop "Optimising your immunoassay with secondary antibodies" from the 2024 UCL Cancer Symposium major sponsor Stratech.

Come along on the journey to discover how to optimise your immunoassay with secondary antibodies and hear more about:

Choosing the right secondary antibody format and conjugate selection for your application.
Cross-reactivity and cross-adsorbed secondary antibodies.
Setting up your experiments for immunofluorescent or colorimetric IHC/ICC, Western Blotting, ELISA, Flow Cytometry, and including multiplexing.
Control and Blocking reagents.

Speaker Biography:

Dr Helen Arnold is Business Development Manager at Stratech partner Jackson ImmunoResearch specialising in secondary antibodies and conjugates. Helen obtained her first degree from the University of Surrey in Biomedical Sciences with an industrial placement year at GlaxoSmithKline (GSK). She completed a PhD at the University of Glasgow in Cardiovascular Cell and Gene Therapy. She then moved to industry to support advancement of Cell and Gene Therapy at Oxford Biomedica and GSK. Helen then moved to the Biotechnology sector and was located to Cambridge to be a part of a startup company in Antibody Development for In Vitro Diagnostics, which then followed by Helen moving to New England Biolabs (NEB) UK to support the advancement and innovation in life sciences R&D.

Cancer Symposium Brochure

The 2024 Cancer symposium brochure and abstract booklet is available to download:

UCL Cancer Symposium Brochure

UCL Cancer Symposium 2024 Poster Booklet

Register for the Cancer Symposium

The symposium will be held at the Kennedy Lecture Theatre at the UCL Great Ormond Street Institute of Child Health on Wednesday 1 May 2024. The symposium is free to attend with lunch provided and all are welcome to attend.